25 related articles for article (PubMed ID: 15940021)
21. Maternal treatment with MCI-186 does not improve delayed deterioration of cellular bioenergetic state and mitochondrial activity following transient intrauterine ischemia in the fetal rat brain.
Yokota A; Nakai A; Taniuchi Y; Okuda N; Nakai M; Takeshita T
J Nippon Med Sch; 2005 Apr; 72(2):127-30. PubMed ID: 15940021
[TBL] [Abstract][Full Text] [Related]
22. Role of mitochondrial permeability transition in the immature brain following intrauterine ischemia.
Nakai A
J Nippon Med Sch; 2007 Jun; 74(3):190-201. PubMed ID: 17625367
[TBL] [Abstract][Full Text] [Related]
23. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
Tanaka M
Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
[TBL] [Abstract][Full Text] [Related]
25. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat.
Nakai A; Kuroda S; Kristián T; Siesjö BK
Neurobiol Dis; 1997; 4(3-4):288-300. PubMed ID: 9361306
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
